Missing trials in drug regulatory dossiers may have good reasons, but should be predefined and transparent
DSpace/Manakin Repository
Missing trials in drug regulatory dossiers may have good reasons, but should be predefined and transparent
Leufkens, Hubert G.
(2022) Journal of Clinical Epidemiology, volume 142, pp. 258 - 260
(Comment)
Download/Full Text
Open Access version via Utrecht University Repository
Publisher version
Keywords: Epidemiology
DOI:
https://doi.org/10.1016/j.jclinepi.2021.10.026
ISSN: 0895-4356
(Peer reviewed)
See
more statistics
about this item